A total manufacturing process for Dolichos lablab Linne extract (DL-Ex), a potential functional food ingredient, was proposed. The standardized manufacturing conditions for extraction and powdering process were optimized to obtain an efficient and economical process. The feasibility of manufacturing...
A total manufacturing process for Dolichos lablab Linne extract (DL-Ex), a potential functional food ingredient, was proposed. The standardized manufacturing conditions for extraction and powdering process were optimized to obtain an efficient and economical process. The feasibility of manufacturing process was optimized on a pilot-scale. Furthermore, a marker compound Dolichos lablab L. extract, Chikusetsusaponin IVa, was identified and analytical method was established. Additionally, optimal formulation types were developed using the DL-Ex.
First of all, the extraction method of DL-Ex was optimized, the marker compound, Chikusetsusaponin IVa in DL-EX was determined and its analysis conditions were validated using HPLC and liquid chromatography mass spectrometry (LC/MS). The highest total Chikusetsusaponin IVa contents in DL-Ex was extracted in a 50% ethanol aqueous solution at 100℃ for 3 hr under reflux extraction methods.
The highest total Chikusetsusaponin IVa contents in DL-Ex was extracted in a 50% ethanol aqueous solution at 100 ℃ for 3 hr under reflux extraction methods. The other hand, highest extraction yield of DL-Ex was shown in a 100% aqueous solution at same condition.
Next, a formulated functional product using the DL-Ex as a major ingredient was developed. The dosage from was selected as tablet. In addition to DL-Ex, various main ingredients such as cellulose, magnesium stearate, silicon dioxide were used. The formulation was established through sensory evaluations and quality controls.
In conclusion, this study shows that the optimal extraction method, the detail manufacturing conditions including powdering process, and the reproducible quantitative analysis of Chikusetsusaponin IVa, a marker compound of DL-Ex, were established. In addition, formulating condition for a tablet product was established for industrial application.
A total manufacturing process for Dolichos lablab Linne extract (DL-Ex), a potential functional food ingredient, was proposed. The standardized manufacturing conditions for extraction and powdering process were optimized to obtain an efficient and economical process. The feasibility of manufacturing process was optimized on a pilot-scale. Furthermore, a marker compound Dolichos lablab L. extract, Chikusetsusaponin IVa, was identified and analytical method was established. Additionally, optimal formulation types were developed using the DL-Ex.
First of all, the extraction method of DL-Ex was optimized, the marker compound, Chikusetsusaponin IVa in DL-EX was determined and its analysis conditions were validated using HPLC and liquid chromatography mass spectrometry (LC/MS). The highest total Chikusetsusaponin IVa contents in DL-Ex was extracted in a 50% ethanol aqueous solution at 100℃ for 3 hr under reflux extraction methods.
The highest total Chikusetsusaponin IVa contents in DL-Ex was extracted in a 50% ethanol aqueous solution at 100 ℃ for 3 hr under reflux extraction methods. The other hand, highest extraction yield of DL-Ex was shown in a 100% aqueous solution at same condition.
Next, a formulated functional product using the DL-Ex as a major ingredient was developed. The dosage from was selected as tablet. In addition to DL-Ex, various main ingredients such as cellulose, magnesium stearate, silicon dioxide were used. The formulation was established through sensory evaluations and quality controls.
In conclusion, this study shows that the optimal extraction method, the detail manufacturing conditions including powdering process, and the reproducible quantitative analysis of Chikusetsusaponin IVa, a marker compound of DL-Ex, were established. In addition, formulating condition for a tablet product was established for industrial application.
주제어
#Dolichos lablab Linne extract, Chikusetsusaponin IVa, Standardized manufacturing conditions, Formulation
※ AI-Helper는 부적절한 답변을 할 수 있습니다.